PharmDr. Leoš Fuksa, Ph.D.

Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove,
Charles University in Prague, Heyrovskeho 1203, Hradec Kralove, 500 05, Czech Republic

Member of: research group of compliance-related outcomes

E-mail: fuksl9aa@faf.cuni.cz
Tel. +420 495067271

Education 

Faculty of Pharmacy in Hradec Kralove, Charles University in Prague

2010

Ph.D. in Pharmacology and Toxicology

2004

Magister degree in Pharmacy (equiv. M.Sc.)

 

Professional experience

Since 2012

Reasearch fellow and external teacher, Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague

Since 2015

Market Access Manager, Sanofi

2009–2015

Pharmacology manager, Department of Drugs and Medical Devices, General Health Insurance Company of the Czech Republic, Prague

2008–2009

Scientific assessment manager and coordinator, Department of Pricing and Reimbursement, State Institute for Drug Control, Prague

2005- 2010

Pharmacist (part-time) in a community pharmacy (various)

2004–2012

Internal postgraduate fellow and assistant, Depratment of Pharmacology, Faculty of Medicine in Hradec Kralove, Charles University in Prague

2003–2004

Scholarship holder, Department of Pharmacology, Faculty of Pharmacy, University La Sapienza in Rome, Italy (M.Sc. Diploma Thesis Project, Erasmus Programme)

Research Interests

  • National drug policies
  • Drug Market Access
  • Drug utilization and expenditure
  • Public health
  • Patient compliance

Teaching experience

  • Teaching Pharmacology in General Medicine study programme, Faculty of Medicine in Hradec Kralove
  • Teaching of Social pharmacy, and Pharmacoeconomics and health Technology Assessment at the Faculty of Pharmacy, Charles University in Prague

Professional memberships

  • International Society for Pharmacoeconomics and Outcomes research
  • Czech Pharmacoeconomic Society
  • Czech Society for experimental and Clinical Pharmacology
  • Czech Pharmacists‘ Chamber

Publications

21 publications in impacted journals (Medline, Web of Science)
Sum of IF = 44.061 (July 2015), Sum of citations 149 (136 without self-citations)
h-index = 7 (July 2015)

 

2014-2015

Fuksa L, Vytrisalova M. The adherence to denosumab in the treatment of osteoporosis and its utilization in the Czech Republic. Curr Med Res Opin. 2015 Jun 29:1-28. [Epub ahead of print]

Fuksa L, Vocelka M, Vytrisalova M. The ompact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997-2013 (2015) Health Policy, Available online, March 2015, ISSN 0168-8510, http://dx.doi.org/10.1016/j.healthpol.2015.02.016.

Muchova L, Vanova K, Suk J, Micuda S, Dolezelova E, Fuksa L, Cerny D, Farghali H, Zelenkova M, Lenicek M, Wong RJ, Vreman HJ, Vitek L. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis (2015) J Cell Mol Med. Feb 16.

Vytrisalova M, Touskova T, Ladova K, Fuksa L, Palicka V, Matoulkova P, Horak P, Stepan J. Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter (2015) Climacteric 24:1-9.

Vytrisalova M, Fuksa L, Palicka V, Byma S, Blazkova S, Stepan J, Hendrychova T, Vlcek J, Pavek P. Adherence to osteoporosis guideline: survey among Czech general practitioners (2014) Central European Journal of Medicine 9(5):687-693

Fuksa L, Vytrisalova M, Hendrychova T, Hrubesova I, Vlcek J, Palicka V. Consumption of osteoanabolic drugs and strontium ranelate in the treatment of osteoporosis in the Czech Republic in 2005-2011 (2014) Acta Pol Pharm 71(2):329-35.

Grants Received

  • Co-investigator IGA NS/10373-3/2009 „Neoadjuvant therapy of breast cancer; Molecular profiling“ (2009-2011);
  • the main investigator GA UK č. 116807 “Study of regulatory mechanisms of drug elimination during liver injury“ (2006-2008),
  • co-investigator GA UK č. 92/2005/C “Cytochrome P450 3A4 and multidrug resistance proteins MDR1 and MRP2 as a cause of drug-drug interactions at the elimination level“ (2005-2006)
  • co-investigator COST B25.001 č.1P05OC061 „Physiologically based prediction of pharmacokinetics prior to in vivo studies: Focus on hepatic and renal elimination” (2005-2008).

 

© 2017 Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic

Powered by Kentico